IKARIA® TO PRESENT AT 31st ANNUAL COWEN AND COMPANY HEALTHCARE CONFERENCE Clinton, NJ, March 2, 2011 – Ikaria, Inc. today announced that its Chairman and CEO, Daniel Tassé, will present at the 31st Annual Cowen and C - Cowen Group - Document - PDFSEARCH.IO

First Page	Meta Content
	IKARIA® TO PRESENT AT 31st ANNUAL COWEN AND COMPANY HEALTHCARE CONFERENCE Clinton, NJ, March 2, 2011 – Ikaria, Inc. today announced that its Chairman and CEO, Daniel Tassé, will present at the 31st Annual Cowen and C Add to Reading List Document Date: 2011-06-28 11:53:08 Open Document File Size: 61,12 KB Share Result on Facebook City Madison / Seattle / Port Allen / Boston / / Company Ikaria Inc. / / Country Puerto Rico / Japan / Canada / Australia / Mexico / / Event M&A / FDA Phase / / IndustryTerm manufacturing facility / drug product / treatment of hypoxic respiratory failure / treatment for hepatorenal syndrome / / MedicalCondition pulmonary hypertension / subsequent congestive heart failure / hypoxic respiratory failure / acute myocardial infarction / / MedicalTreatment innovative therapies / / Organization FDA / / Person Daniel Tassé / Clinton / / Position Chairman and CEO / / Product INOMAX / INOMAX® / / ProvinceOrState Wisconsin / Louisiana / Washington / / URL www.ikaria.com / / SocialTag Hepatorenal syndrome Syndromes Ikaria Cowen Group Food and Drug Administration Health Pharmaceutical sciences Medicine

IKARIA® TO PRESENT AT 31st ANNUAL COWEN AND COMPANY HEALTHCARE CONFERENCE Clinton, NJ, March 2, 2011 – Ikaria, Inc. today announced that its Chairman and CEO, Daniel Tassé, will present at the 31st Annual Cowen and CAdd to Reading List